α-Cell deficit in obese type 2 diabetes, a minor role of α-Cell dedifferentiation and degranulation

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 2, 2016, Pages 523-532

  Butler, Alexandra E ^a   Dhawan, Sangeeta ^a   Hoang, Jonathan ^a   Cory, Megan ^a   Zeng, Kylie ^a   Fritsch, Helga ^b   Meier, Juris J ^c   Rizza, Robert A ^d   Butler, Peter C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c ST JOSEF HOSPITAL   (Germany)

^d Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; GHRELIN; GLUCAGON; INSULIN; PANCREAS POLYPEPTIDE; SOMATOSTATIN;

ADULT; AGED; ARTICLE; AUTOPSY; CELL COUNT; CELL DEDIFFERENTIATION; CELL REGENERATION; CELL TRANSDIFFERENTIATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; EMBRYO; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORGANOGENESIS; PANCREAS; PANCREAS DEVELOPMENT; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TISSUE DISTRIBUTION; AGE; BODY MASS; COMPLICATION; PATHOLOGY;

AGE FACTORS; AGED; AUTOPSY; BODY MASS INDEX; CELL DEDIFFERENTIATION; CELL DEGRANULATION; DIABETES MELLITUS, TYPE 2; HUMANS; INFANT, NEWBORN; INSULIN-SECRETING CELLS; MIDDLE AGED; OBESITY; PANCREAS;

EID: 84959440522     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3566     Document Type: Article

References (32)

1. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic α-Cell function and prevention of type 2 diabetes by pharmadoicological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796-2803.
2. Xiang AH, Takayanagi M, Black MH, et al. Longitudinal changes in insulin sensitivity and cell function between women with and without a history of gestational diabetes mellitus. Diabetologia. 2013;56:2753-2760.
3. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res. 1985;4:110-125.
4. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. α-Cell deficit and increased beta α-Cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-110.
5. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic α-Cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10(suppl 4):32-42.
6. Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes. 2013;62:2595-2604.
7. Mukherjee A, Morales-Scheihing D, Butler PC, Soto C. Type 2 diabetes as a protein misfolDing disease. Trends Mol Med. 2015;21: 439-449.
8. Matveyenko AV, Butler PC. α-Cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes. 2006;55:2106-2114.
9. Ashe KH, Zahs KR. Probing the biology of Alzheimer's disease in mice. Neuron. 2010;66:631-645.
10. Rivera JF, Costes S, Gurlo T, Glabe CG, Butler PC. Autophagy defends pancreatic cells from human islet amyloid polypeptideinduced toxicity. J Clin Invest. 2014;124:3489-3500.
11. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell. 2012;150:1223-1234.
12. Meier JJ, Butler AE, Saisho Y, et al. α-Cell replication is the primary mechanism subserving the postnatal expansion of α-Cell mass in humans. Diabetes. 2008;57:1584-1594.
13. Marselli L, Suleiman M, Masini M, et al. Are we overestimating the loss of cells in type 2 diabetes? Diabetologia. 2014;57:362-365.
14. Butler AE, Robertson RP, Hernandez R, Matveyenko AV, Gurlo T, Butler PC. Cell nuclear musculoaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes. Diabetologia. 2012;55:2985-2988.
15. Guo S, Dai C, Guo M, et al. Inactivation of specific cell transcription factors in type 2 diabetes. J Clin Invest. 2013;123:3305-3316.
16. Spijker HS, Song H, Ellenbroek JH, et al. Loss of α-Cell identity occurs in type 2 diabetes and is associated with islet amyloid deposits. Diabetes. 2015;64:2928-2938.
17. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC. Relationship between α-Cell mass and fasting blood glucose concentration in humans. Diabetes Care. 2006;29:717-718.
18. Meier JJ, Menge BA, Breuer TG, et al. Functional assessment of pancreatic α-Cell area in humans. Diabetes. 2009;58:1595-1603.
19. Kjems LL, Kirby BM, Welsh EM, et al. Decrease in α-Cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes. 2001;50:2001-2012.
20. Saisho Y, Butler AE, Manesso E, et al. Relationship between fractional pancreatic cell area and fasting plasma glucose concentration in monkeys. Diabetologia. 2010;53:111-114.
21. Matveyenko AV, Veldhuis JD, Butler PC. Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes. 2006;55:2347-2356.
22. Laybutt DR, Preston AM, Akerfeldt MC, et al. Endoplasmic reticulum stress contributes to cell apoptosis in type 2 diabetes. Diabetologia. 2007;50:752-763.
23. Huang CJ, Lin CY, Haataja L, et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated α-Cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes. 2007;56:2016-2027.
24. Marchetti P, Del Guerra S, Marselli L, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab. 2004;89:5535-5541.
25. Gurlo T, Ryazantsev S, Huang CJ, et al. Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol. 2010;176:861-869.
26. Howard CF Jr. Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia. 1986;29:301-306.
27. Butler AE, Dhawan S. α-Cell identity in type 2 diabetes: lost or found? Diabetes. 2015;64:2698-2700.
28. Meier JJ, Kohler CU, Alkhatib B, et al. α-Cell development and turnover during prenatal life in humans. Eur J Endocrinol. 2010; 162:559-568.
29. Butler AE, Cao-Minh L, Galasso R, et al. Adaptive changes in pancreatic cell fractional area and cell turnover in human pregnancy. Diabetologia. 2010;53:2167-2176.
30. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science. 2004;306: 2261-2264.
31. Talchai SC, Accili D. Legacy Effect of Foxo1 in pancreatic endocrine progenitors on adult α-Cell mass and function. Diabetes. 2015;64: 2868-2879.
32. Costes S, Langen R, Gurlo T, Matveyenko AV, Butler PC. α-Cell failure in type 2 diabetes: a case of asking too much of too few? Diabetes. 2013;62:327-335.